Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2008 / Cilt: 14 - Sayı: 2

Postmenopozal hastalarda vaginal kandidiyaz ile hormon tedavisi arasındaki ilişki

The relationship between hormone therapy and vaginal candidiasis in postmenopausal patients

Pages
107–109
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Key Words: Candida colonization, Hormonal therapy, Vaginal candidiasis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To evaluate the role of hormone therapy on vaginal Candida infection and colonization.
📊
Key Findings & Data:Sample for yeast culture was taken at the beginning and again at the end of 3rd and 6th months of the study.
💡
Conclusion & Impact:Key Words: Candida colonization, Hormonal therapy, Vaginal candidiasis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To evaluate the role of hormone therapy on vaginal Candida infection and colonization. STUDY DESIGN: The patients in postmenopausal period attending to gynecology clinics were entered the study prospectively. The patients were classified as hormone therapy and control groups. Patients who used hormonal therapy, immunocompromised and having hysterectomy were excluded from the study. Sample for yeast culture was taken at the beginning and again at the end of 3rd and 6th months of the study. Sabouraud dextrose agar medium was used for yeast culture and positive culture showing yeast morphology was typed with conventional and full automatic yeast identification systems. Two groups were compared with Chi-Squared and T test using SPSS 10 statistical software program and p <0.05 was accepted to be statistical significant. RESULTS: Totally, 112 patients completed the study. Hormonal therapy group consisted of 52 patients and control group consisted of 60 patients. There was no statistical significant difference in demographic characteristics between two groups. Candida culture positivity was more frequent in the hormonal therapy group at the 3rd and 6th months of the treatment and follow up(p <0.05). But, clinical infections were not different in two groups (p >0.05). The most frequent type of Candida isolated culture was Candida glabrata. CONCLUSION: Hormonal therapy increases vaginal Candida colonization but not infection. Key Words: Candida colonization, Hormonal therapy, Vaginal candidiasis

Özet

Hormon tedavisinin vaginal kandida enfeksiyonu ve kolonizasyonu üzerindeki rolünü değerlendirmek. Postmenopozal dönemde olup jinekoloji kliniğine başvuran hastalar prospektif olarak çalışmaya alındı. Hastalar hormon tedavisi grup ve kontrol grubu olarak ikiye ayrıldı. Hormon tedavisi alanlar, immün sistemi bozuk olanlar ve histerektomize hastalar çalışmaya dahil edilmedi. Mantar için kültür çalışma başında, izlemin 3. ve 6. aylarında alındı. Saburoid dextroz ağar besi yeri mantar kültürü için kullanıldı ve üreme olan örnekler konvansiyonel ve tam otomatik mantar identifikasyon sistemi ile tiplendirildi. İki grup SPSS 10 istatistik programı kullanılarak Ki-Kare ve T testi ile karşılaştırıldı ve p 0.05). Kültürde izole edilen en sık tip kandida glabrata idi'Hormon tedavisi kandidal kolonizasyonu artırmaktadır. Ancak klinik enfeksiyon sıklığına etki etmemektedir.

🔖

Cite This Article

ÖZYURT, H., ŞİMŞEK, T., ÖNGÜT, G., ÖĞÜNÇ, D. (2008). Postmenopozal hastalarda vaginal kandidiyaz ile hormon tedavisi arasındaki ilişki. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 14 - Sayı: 2, 107–109. https://ajindex.com/articles/227064

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Rossouw JE, Anderson GL, Prentice RL et all: Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 17:288-321-33. 2.Million Women Study Collaborators. Paterns of use of hormone replacement therapy in one million women in Britain 1996-2000. BJOG 2002;109:1319-30. 3.Hulley S, Furberg C, Barret-Connore E et all: HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/prog-estin Replacement Study follow-up (HERS II). JAMA. 2002;288:58-66. 4.Manonai J, Chittachareon A and Theppisia U. Effect of estradiol valerate and levonorgestrel on vaginal health. Eur J Obstet & Gynecol and Reprod Biol 2004; 115:190-3. 5.Devilard E, Burton PJ, Hammond Jo-Anne, Lam D and Reid G. Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophore-sis. Eur J Obstet Gyne and Repr Biol 2004;117:76-81. 6.Cauci S, Driussi S, Santa De Davide et all. Prevalance of Bacterial Vaginosis and Flora Changes in Peri- and Postmenopausal Women. Journal of Clinical Microbiology 2002;40:2147-52. 7.Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152:924-35. 8.Milsom I, Ardvisson L, Ekelund P, Molander U, Erikson O. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 1993; 72:286-91. 9.McCormack WM, Starko KM, Zinner SH. Symptoms associated with vaginal colonization with yeast. Am J Obstet Gynecol 1988;158:31-3. 10.Horowitz BJ, Edelstein S W, Lippman L. Candida tropi-calis vulvovaginitis. Obstet Gynecol 1985;66:229-32. 11.Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis Am J Obstet Gynecol 1985; 152:924-35.